title: Factors involved in the delay of treatment initiation for cervical cancer patients: A nationwide population-based study.
abstract: Cervical cancer ranks as the fourth leading cause of cancer death in women worldwide. In Taiwan, although the universal health insurance system has achieved 99.9% coverage and ensured easy access to medical care, some cervical cancer patients continue to delay initiation of definitive treatment after diagnosis. This study focused on cervical cancer patients who delayed treatment for at least 4 months, and examined the characteristics, related factors, and survival in these patients.Data on patients with a new confirmed diagnosis of cervical cancer by the International Federation of Gynecology and Obstetrics (FIGO) staging system between 2005 and 2010 were obtained from the National Health Insurance Research Database and the Taiwan Cancer Registry. Logistic regression analysis was performed to analyze the association of various factors with treatment delay. The Cox proportional hazards model was used to analyze the effects of various factors on mortality risk.The rate of treatment delay for cervical cancer decreased steadily from 6.46% in 2005 to 2.48% in 2010. Higher rates of treatment delay were observed among patients who were aged ≥75 years (9.91%), had severe comorbidity, had stage IV (9.50%), diagnosing hospital level at nonmedical center, or at public hospital ownership. Factors that correlated with treatment delay were age ≥75 years (odds ratio [OR] = 2.42), higher comorbidity Charlson comorbidity index (CCI) 4-6, or ≥7 (OR = 1.60, 2.00), cancer stage IV (OR = 2.60), the diagnosing hospital being a regional, district hospital, or other (OR = 3.00, 4.01, 4.60), and at public hospital ownership. Those who delayed treatment had 2.31 times the mortality risk of those who underwent timely treatment (P < 0.05).Delayed cervical cancer treatment in Taiwan was associated with age, comorbidity, cancer stage, diagnosing hospital level, and hospital ownership. Delaying treatment for ≥4 months substantially raised mortality risk in cervical cancer patients.
authors.affiliation: Department of Public Health Department of Health Services Administration, China Medical University, Taichung Department of Medical Affairs, Buddhist Dalin Tzu Chi Hospital, Chiayi Department of Health Services Administration, Chia Nan University of Pharmacy and Science, Tainan Department of Obstetrics and Gynecology, China Medical University Hospital Graduate Institution of Clinical Medical Science, School of Medicine, China Medical University Department of Healthcare Administration, Asia University, Taichung, Taiwan.
authors.forename: Szu-Ching
authors.initials: SC
authors.lastname: Shen
authors.forename: Yao-Ching
authors.initials: YC
authors.lastname: Hung
authors.forename: Pei-Tseng
authors.initials: PT
authors.lastname: Kung
authors.forename: Wen-Hui
authors.initials: WH
authors.lastname: Yang
authors.forename: Yueh-Hsin
authors.initials: YH
authors.lastname: Wang
authors.forename: Wen-Chen
authors.initials: WC
authors.lastname: Tsai
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D005260:Female; D006801:Humans; D016015:Logistic Models; D008875:Middle Aged; D016016:Proportional Hazards Models; D012042:Registries; D013624:Taiwan; D013997:Time Factors; D002583:Uterine Cervical Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*